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                                                        ABSTRACT 
 
Purpose: The purpose of this study was to estimate the costs of medical detoxification 
among patients with alcohol and substance abuse disorders. 
Design/methodology/approach: The study data was drawn from a medical 
detoxification program in a community hospital in Texas. Secondary data analysis of 
1337 cases from three years was reviewed. Age, gender, race, alcohol, cocaine, cannabis, 
amphetamines, sedatives, opioids, financial classification, cost, Length of Stay (LOS) and 
cost by LOS were analyzed using Kruskal–Wallis test and Mann Whittney U test. 
Findings: The sample comprised of 42.8% women and 57.2% males. The mean cost and 
cost by LOS was highest for cocaine ($2,560.1 & $1,044, P<.01), while opioid and 
cannabis ($815.5, p<.01; $823.7, p<.01) had significantly higher values than the rest. In 
each individual drug detoxification class, except for amphetamines, the mean and median 
LOS has been reported to be less among the uninsured category compared to privately 
insured subjects. In addition, the cost by LOS was also found to be higher in the 
uninsured group compared to those with private insurance. Subjects who were uninsured 
and abused alcohol had higher median costs of detoxification (P<.01) by LOS. Research 
limitations/ implications: Further in-depth analysis for confounding and interactions 
between variables is warranted. Originality/value: This research provides an estimation 
of LOS of a medical detoxification program by financial class in the US and illustrates 
that early discharge of uninsured and Medicaid patients can be attributable to aggressive 
case management practices, interrupting the normal course of care. 
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INTRODUCTION 
 
According to Healthy People 2010, health disparities are defined as differences in 
morbidity and mortality that occur by gender, race or ethnicity, income or education 
level, disability, geographic location or sexual orientation (U.S. Department of Health 
and Human Services, 2000). The existence of racial and ethnic disparities in health care 
represents the failure of the healthcare system to provide equal, high quality health care 
to all individuals, regardless of ethnicity, race and other factors.  The publication of 
Healthy People 2010 advanced a goal for the elimination of all health disparities in the 
United States, and acknowledged that a comprehensive strategy incorporating research, 
education, policy changes, and community partnerships is fundamental to accomplishing 
this goal (U.S. Department of Health and Human Services, 2000).  Lack of health 
insurance coverage represents a major barrier to health care utilization and is associated 
with having poorer physical and mental health (Wu, Kouzis, and Schlenger, 2003). 
According to 2006 U.S Census Bureau, there were 47 million uninsured people or 16% of 
the population, in the year 2005 (DeNavas-Walt, Proctor, and Smith, 2007). Hispanics 
were least likely to have health insurance (32.7%), followed by Non-Hispanic Blacks 
(NHB) (19.6%) and Non-Hispanic Whites (NHW) (11.1%). Racial and ethnic differences 
persist in access to managed care (Hargraves, Cunningham, & Hughes, 2001). For all 
ethnic/racial groups, financial barriers, including being uninsured, underinsured and 
publicly insured, hinder timely access to the healthcare system (Weinick, Zuvekas, & 
Cohen, 2000; Aday, 2001; Langwell & Moser 2002), and parity for health and mental 
health care insurance has been opposed by employers and insurance companies as too 
costly.  
Race and ethnicity are predisposing factors that can also affect access to mental 
health services or substance abuse treatment (Snowden, 2001; Wang, Demler, Kessler, 
2002). According to the substance abuse and mental health administration (SAMHSA), 
access to substance abuse treatment can be affected by race/ethnicity factors and 
urbanization of residence among others (SAMHSA, 1998). As a result, non-Hispanic 
Blacks and Hispanics are likely to receive fewer mental health services or less substance 
abuse treatment than needed (Wells, Klap, Koike, & Sherbourne, 2001). In addition, 
several studies have shown that for patients with substance use disorders entering 
treatment, there has been a substantial post treatment decline in the utilization and costs 
of hospital and emergency room services (Stein, O’Sullivan, Ellis, Perrin, & Wartenberg, 
1993; Parthasarathy, Weisner, Hu, & Moore, 2001).  
Substance use disorders, currently, are among the most costly medical and public 
health problems in the United States (Califano, 1998; McLellan, Lewis, O’Brien, & 
Kleber, 2000).  In 2004, an estimated 22.5 million Americans, or 9.4% of total 
population, were classified with substance dependence or abuse (National Survey on 
Drug Use and Health [NSDUH], 2004).  Drug abuse and addiction have a significant 
impact on individual lives, families, and communities, which is devastating. Illicit drugs 
enter Texas from Mexico through cities such as El Paso, Laredo, McAllen, and 
Brownsville, as well as through smaller towns along the border (Maxwell, 2006). Texas 
has lost about 13,518 lives in 2000, due to alcohol- and drug-related causes, which 
comprised nine percent of total deaths of the state. In terms of age distribution, substance 
related deaths accounted for more than one-third (38%) of all deaths among 15- to 24-
year-olds (Liu, 2000). The 2002-2003 NSDUH, ranked Texas as one of the ten states 
with lowest substance abuse and dependence facilities, with only 7.15% of its population 
and 556 reported treatment facilities (SAMHSA, 2005). In 2005, among the total 
admissions to the Texas Department of Health and Human Services funded treatment 
programs, heroin and other opiates together accounted for 13.6% of the admissions while 
alcohol accounted for 23.9% and crack cocaine 17.4 % (Maxwell, 2006). The average 
age at which admissions occurred was 35.6 years for heroin, 34.5 years for other opiates, 
and 37.1 years for alcohol and 25.5 years for crack cocaine. Percentage of emergency 
room visits were 31.3%, 53.3%, 35.9% and 39.1% for heroin, other opiates, alcohol and 
crack cocaine, respectively. Heroin was responsible for 54.5% of employment problems 
while alcohol and crack cocaine were attributable to 55.8% and 62% of same problem 
respectively (Maxwell, 2006).   
Medical detoxification is the process where by individuals are systematically 
withdrawn from addictive drugs in an inpatient or outpatient setting, typically under the 
care of a physician (National Institute on Drug Abuse [NIDA], 2005). Detoxification is 
sometimes called a distinct treatment modality but is more appropriately considered a 
precursor of treatment, because it is designed to treat the acute physiological effects of 
stopping drug use. Medications are available for detoxification form opiates, cocaine, 
benzodiazepines, alcohol, barbiturates, and other sedatives. In some cases, detoxification 
may be a medical necessity, and untreated withdrawal may be medically dangerous or 
even fatal (NIDA, 2005).  
                                        METHODOLOGY  
    
Study population: The study was performed in a 215 bed, non-profit, standalone 
hospital in Texas, which was the primary hospital for a local medical school. This 
medical facility contracted services with a national detoxification program that provided 
inpatient emergency medical detoxification services for adults with alcohol and drug 
related problems. All individuals, eighteen years or older (n=1,342), receiving medical 
detoxification services from fiscal year 2001 to fiscal year 2003, were identified using the 
detoxification program database. Five cases were excluded as their Length of Stay [LOS] 
was 0 as they were patients discharged Against Medical Advised (AMA).  
Study variables:  
Variables considered were age, gender, race/ethnicity, and financial class, 
utilization of alcohol, cocaine, opioid; cost, length of stay and cost by length of stay. Age 
was categorized into four groups: 18-34, 35-49, 50-64 and 65 and older. Race/ethnicity 
was self-determined and recorded as NHW, NHB, Hispanic, and Other. Other category 
included individuals of Asian, Native American, or Unknown ethnicity/race. Subjects 
were categorized into six different financial classifications according to their method of 
payment for medical detoxification services: Private, Medicare, Medicaid, Self-pay, 
Uninsured and Other. Private health insurance included insurance provided by employer 
or obtained by direct payment from a private health insurance company. Self-pay 
included individuals not covered by any private or public programs or above mentioned 
sources. Payments from workers compensation, state and federal funded agencies were 
classified as Other. 
 Individuals were classified as multi-drug users according to their self-support of 
drug abuse: use of a single substance, or more than one substance at the moment of 
intervention. Relapse was defined as seeking and receiving detoxification services on 
more than one occasion during the three-year period under study. Length of Stay was 
recorded as the total number of days an individual stayed at the hospital during treatment.  
Data analysis: All hypothesis tests were two-tailed, and statistical significance was 
assessed at the 0.05 level. Data that deviated significantly from normality were analyzed 
using non-parametric methods (Mann Whitney U test or Kruskal Wallis H test). Costs 
were calculated as 33% of charges based on Friedman, Mare, Andrews, and McKenzie 
estimation (Friedman et al., 2002) and costs by LOS. This model is based upon hospital 
characteristics and takes into account the number of beds, being a rural or urban setting, 
hospital type of ownership, and whether each hospital is a teaching or non-teaching 
hospital. All statistical analyses used SPSS 12.0. This study protocol sought and received 
appropriate approvals related to the protection of human subjects from the Institutional 
Review Board of the University of North Texas Health Science Center. 
                                  RESULTS 
 
Sample description:  One thousand three hundred thirty seven individuals seeking 
medical detoxification services were included in the analysis. The sample comprised of 
42.8% women and 57.2% males (Table 1). More than half of the subjects in NHW, NHB 
and Hispanics, respectively, were between the 35 and 49 years old (Table 1). Subjects 
with Medicaid were more in number in all the three races, with the percentages being 
30.5%, 45.9% and 35.1% in NHW, NHB and Hispanics, respectively. Hispanics were 
more likely to be uninsured compared to Other races, while whites were more likely to 
have private insurance and blacks used more Medicaid services (Table 1). 
 
Table 1 about here 
 
The mean cost by length of stay was higher for cocaine ($1044, p<.01), opioid 
($815.5) and cannabis ($823.7) detoxification when compared to other drugs and was 
statistically significant. The mean total cost of detoxification services for cocaine 
($2560.1) was significantly higher than those of other drugs (Table 2).    
 
Table 2 about here 
 
 
Findings in Table three indicate that subjects under amphetamine category with 
Medicaid had significantly higher mean and median costs of detoxification ($2,454.8 and 
$1,651, respectively) compared to Other.   
 
Table 3 about here 
 
 In each individual drug detoxification, except for amphetamines, the mean and 
median length of stay has been reported to be less among the uninsured category 
compared to privately insured subjects. In addition, the cost by length of stay was also 
found to be higher in the uninsured group compared to those with private insurance. 
Subjects who were uninsured and abused alcohol had significantly higher median costs of 
detoxification ($2,144.6, p<.05) compared to Other (Table 4).  
 
Table 4 about here 
 
            DISCUSSION 
Non-Hispanic Blacks were more likely to be insured compared to NHW, mostly 
by public insurance, but this did not hold for Hispanics, who were about three times more 
likely to be uninsured compared to NHB. Traditionally the Hispanic population has been 
the minority group with the highest proportion of individuals without insurance. Multiple 
factors might be interacting to produce such phenomenon, such as illegal immigration 
status, low education attainment and low income, and temporary employment without 
health benefits. These factors have been considered as primary level barriers in Carrillo’s 
model (Carrillo, Trevino, Betancourt, Coustasse, 2001).   
The findings reported that Hispanics were more likely to be uninsured and have 
lower LOS. These findings could in fact indicate that uninsured Hispanics, as well as 
Hispanics on Medicaid, were being discharged earlier from this acute detoxification 
center, which was one of the primary access facilities to the healthcare system for most 
uninsured and Medicaid individuals with substance abuse. Early discharge of uninsured 
and Medicaid patients can be attributable to aggressive case management practices. This 
in turn, can interrupt the normal course of care, and hinders timely access to further 
treatment, such as rehabilitation. In fact, the waiting period for the only public 
rehabilitation facility in the county was approximately 21 days (TCC, 2004).    
In the United States, the estimated societal economic cost of drug abuse in 2002, 
which included health care costs, productivity losses and costs associated with criminal 
justice system, crime victim costs and expenses for administration related with social 
welfare system was $180.8 billion (ONDCP, 2004). Drug abuse is inextricably linked 
with the spread of infectious diseases such as HIV/AIDS, STD's, tuberculosis, hepatitis 
C, and is also associated with domestic violence, crime in the community, child abuse, 
accidents, teenage pregnancies and other adverse effects (U.S. Department of Health and 
Human Services, 2004).  Furthermore, in 2002 there were 1.35 million inmates in US 
state and federal prisons, of which 329,000 or 24.4% were for drug offenses, and another 
134,000 or 9.9% were for drug-related offenses (ONDCP, 2004). 
 For the period 1992-2002 the overall economic cost of drug abuse to society 
increased at a rate of 5.3% annually, from $107.5 to $180.8 billion (ONDCP, 2004). The 
consequences of alcohol and drug abuse show significant costs to Texas in medical 
resources used for treatment and care, reduced and/or lost productivity, law enforcement, 
destruction of property, and in motor vehicle accidents. The total economic costs of 
alcohol and drug abuse in Texas were estimated at $25.9 billion for 2000. Alcohol abuse 
cost has been roughly calculated to be $16.4 billion (63 %), while drug abuse or 
dependency was accounted for $9.5 billion (37 %), (Liu, 2000). In the same year, about 
$679 million was spent on specialty treatment services for alcohol and other drugs (Liu, 
2000). An estimated $286 million was spent to treat clients primarily for alcohol abuse 
and $393 million primarily for drug dependence. The 2000-2003 Consolidate Plan for the 
city of Fort Worth, Texas, has indicated that substance abuse was the most important 
reason for homelessness and emphasizes it as a high priority need (SAMHSA, 2005). 
Several limitations of the current study should be considered before conclusions are 
drawn. Two of the major concerns were about potential information bias due to self-
reporting of drug abuse by patients, and failure to include substance abuse severity, 
and/or other medical conditions amongst patients that might have confounded our 
findings. In addition, other demographic and socioeconomic variables were not available, 
as this database was independent from the clinical and billing systems of the hospital. 
Finally, further in-depth analysis for confounding and interactions between variables is 
warranted.     
Substance abuse is a major public health problem, it affects the health of a vast 
number of Americans, and results in remarkable costs to the healthcare system in the 
United States, and to society in general. The public health community must provide 
strong leadership in informing policy, advocating for needed research funds, and bringing 
practice in line with scientific advances in substance abuse prevention and treatment. 
Publicly funded treatment could pave the way. An effective strategy might consist of 
making significant improvements in the coverage and quality of substance abuse 
treatment under Medicaid and the Substance Abuse Treatment Block Grant Program, 
which currently requires insufficient accountability for the use of treatment dollars. 
Increased public coverage would reach the poorest populations, among whom the most 
chronic and complex drug users are most prevalent. At the same time, it is critical to 
improve the delivery of substance abuse treatments funded by Medicaid and the block 
grants through the adoption of protocols and models based on proven methods. This 
would enable providers to staff programs with an appropriately trained workforce, match 
the length of treatment to the level of client impairment, and provide more 
comprehensive and culturally competent services that are needed by individuals addicted 
to drugs and alcohol.     
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Table 1: Demographic Characteristics and Financial Classification by Race in a 
Medical Detoxification Program, 2000-2003 
Demographic 
Characteristics 
  Race     p         p       p       p 
Sex, Age and 
Financial 
Classification 
N=1337 Non 
Hispanic 
White 
  Non 
Hispanic  
Black 
  Hispanics   Other   
N=928 N=268 N=94 N=47 
Gender by 
Percent 
Females 42.80% 0.07 37.60% 0.14 42.60% 0.78 29.80% 0.1 
Males 57.20% 62.70% 57.40% 70.20% 
Age 
distribution % 
by race  
                  
18-34 20.40% <.01 15.30% <.01 28.70% 0.19 36.20% <.05 
35-49 53.40%  63.80%  50.00%  34.00%   
50-64 18.00%  18.70%  17.00%  23.40%   
>65 8.20%   2.20%   4.30%   6.40%   
Financial 
Classification 
by percent 
within race 
 
  <.01 
 
<.01 
 
0.36 
 
<.05 
  
  
 
 
 
 
 
 
  
Private   27.70%  8.60%  25.50%  21.30%   
Medicare 25.20%  36.90%  22.30%  23.45   
Medicaid 30.50%  45.90%  35.10%  44.70%   
Uninsured   13.60%  7.80%  17.00%  4.30%   
Other   1.40%   0.40%   0.00%   6.40%   
* p values computed by Kruskal-Wallis test and Mann Whitney U test 
 
 
 
 
 
 
Table 2:  Cost, Cost by LOS and LOS in a Medical Detoxification Program, 2000-
2003 
    Cost p 
Value 
Cost/LOS p 
Value 
LOS p 
Value 
Cocaine Mean 2560.1 <.01 1044 <.01 3.1 <.01 
  Median 1822.1  667.1  3   
  SD 4994.5  3100.2  1.917   
Opioid Mean 2696.4 .92 815.5 <.01 3.6 <.01 
  Median 1979.2  670.7  3   
  SD 2532.1  711.6  2.4   
Alcohol Mean 909.1 .61 2814.8 0.78 3.5 .58 
  Median 736.8  2053.8  3   
  SD 786.4  3185.6  2.5   
Cannabis Mean 2339.2 <.01 823.7 <.01 3.3 .633 
  Median 1613.6  578.2  3   
  SD 1954.4  647.7  1.9   
Amphetamines Mean 1821.6 <.01 760.8 .25 2.6 <.05 
  Median 1429.3  627.2  3   
  SD 1260.2  441.1  1.3   
Sedatives Mean 2505.1 .23 832 .34 3.2 .85 
  Median 1852.5  593.5  3   
  SD 2696.4   851.8   1.4   
* p value computed by Kruskal-Wallis test and Mann Whitney U test 
 
 
 
 
 
 
 
Table 3: Comparison of Cost, Cost by LOS and LOS by Drug Type by Private and 
Medicaid Insurance in a Medical Detoxification Program, 2000-2003 
  Cost Cost/LOS LOS 
    Private Medicaid p Private Medicaid p Private Medicaid p 
Cocaine Mean 2416 2905.8 .51 890.9 1286 .58 3.1 3.2 .98 
 Median 1999.3 1812.6  660.7 644.5  3 3   
  SD 1853.1 7348.5  684.1 4664.8  1.5 2.1   
Opioid Mean 2492.6 2640.8 .96 813.6 794.5 .48 3.5 3.6 .89 
 Median 1978.3 1956.6  618.7 686.6  3 3   
  SD 2200.1 2439.1  948.1 608.1  2 2.3   
Alcohol Mean 2646.8 3032.4 .3 891.9 835.4 .84 3.4 3.8 .16 
 Median 1905.3 1940  670.2 653.1  3 3   
  SD 3364.3 4250.3  1064.8 769.2  2.2 2.7   
Cannabis Mean 3206.5 1805 .2 988.7 629 .71 3.8 3.1 .2 
 Median 1783.6 1378  476.8 509.9  3 3   
  SD 2832.3 1026.5  867.1 389.8  2.2 1.3   
Sedatives Mean 2346.7 3099.1 .89 691.5 1113.4 .48 3.5 3 .35 
 Median 2080.1 1808.8  582.6 589.7  3.5 3   
  SD 1233.6 4398.3  254.8 1465.5  1.5 1.1   
Amphetamines Mean 1246.5 2454.8 <.01 748.7 732.8 .81 2 3.4 .03 
 Median 1236.2 1651  623 676.9  2 3   
  SD 353.8 1707.3   358.4 283.7   1.05 1.6   
 * p value computed by Kruskal -Wallis test and Mann Whitney U test 
 
 
 
 
 
 
 
 
Table 4: Comparison of Cost, Cost by LOS and LOS by Drug Type by Private and     
Uninsured patients in a Medical Detoxification Program, 2000-2003 
 Cost Cost/LOS LOS 
    Private Uninsured p Private Uninsured  p Private Uninsured p 
Cocaine Mean 2416 2651.1 .97 890.9 1158.1 .1 3.1 2.9 .17 
  Median 1999.3 1748.1  660.7 910  3 2   
  SD 1853.1 2599.3  684.1 866.3  1.5 2.2   
Opioid Mean 2492.6 3173.2 .65 813.6 1021.1 .14 3.5 3.47 .74 
  Median 1978.3 2209.9  618.7 814.8  3 3   
  SD 2200.1 4016.3  948.1 816.5  2 2.4   
Alcohol Mean 2646.8 2598.8 <.05 891.9 1182.3 <.01 3.4 2.8 <.05 
  Median 1905.3 2144.6  670.2 1074.7  3 3   
  SD 3364.3 1384.05  1064.8 672.4  2.2 2.05   
Cannabis Mean 3206.5 2474.9 .54 988.7 1393.4 .18 3.8 2.6 .1 
  Median 1783.6 1892.4  476.8 1270.08  3 2   
  SD 2832.3 1179.05  867.1 885.87  2.2 1.9   
Sedatives Mean 2346.7 1606.8 .42 691.5 794.49 .49 3.5 2.5 .44 
  Median 2080.1 1606.8  582.6 794.49  3.5 2.5   
  SD 1233.6 791.1  254.8 357.6  1.5 2.12   
Amphetamines Mean 1246.5 2206.8 .1 748.7 1197.5 .15 2 2.1 .69 
  Median 1236.2 2007.2  623 964.4  2 2.5   
  SD 353.8 1236.7   358.4 796.7   1.05 0.98   
* p value computed by Kruskal-Wallis test and Mann Whitney U test 
 
